USDA Feasibility Study Costs in 2026: Pricing, Timelines, and What Lenders Actually Require

A transparent 2026 cost guide for Business and Industry (B&I), REAP, Community Facilities, and Section 9003 feasibility studies, with the regulatory and market context that decides whether an application clears agency review the first time.

At a Glance

In 2026, a USDA-compliant feasibility study for the Business and Industry (B&I) program typically runs from about $7,500 for a straightforward, operating-business engagement to $18,750 or more for projects with layered capital structures and unproven technology. Rural Energy for America Program (REAP) studies generally fall between $5,250 and $11,250. Community Facilities (CF) engagements range from $11,250 to $22,500. Section 9003 biorefinery studies, the most demanding work in the program, begin at roughly $22,500.

Most engagements deliver in two to five weeks, faster than the four to seven weeks that remain common across the market. Fee is governed by complexity, not loan size, and the gap between a defensible study and a rejected one is almost never the headline price. It is the depth of analysis behind it.

This guide lays out current pricing, explains what actually moves the fee, walks through the regulatory standard the agency applies, and clarifies when a study is mandatory and when it is not. The goal is to let a borrower or a lender size an engagement accurately before commissioning it, and to understand why the cheapest option on the market is usually the one that costs the most.

2026 USDA Feasibility Study Pricing

Fees are set by the complexity of the asset class, the depth of market research required, and the program-specific mandates in the 7 CFR Part 5001 OneRD Guarantee regulation. The table below reflects current market positioning for lender-grade, agency-ready studies.

Program	Representative Project Scope	Estimated Cost Range	Typical Timeline
USDA REAP (Energy)	Solar, wind, energy efficiency	$5,250 – $11,250	2 – 3 weeks
USDA B&I / TPEP	Manufacturing, retail, hotels, travel centers, sawmills	$7,500 – $18,750	2 – 4 weeks
USDA Community Facilities	Healthcare, child care, public safety, infrastructure	$11,250 – $22,500	3 – 5 weeks
USDA Section 9003	Biorefineries, biobased products, renewables	$22,500+	6+ weeks

These ranges sit meaningfully below the field for comparable scope, and the timelines compress the typical engagement by roughly two weeks. That is a function of method, not corner-cutting. We explain how further down.

A note on how to read the ranges. The low end of each band corresponds to an operating asset with a documented financial history, abundant comparables, and a clean single-entity ownership structure. The high end corresponds to a ground-up development, a novel concept, or a project carrying multiple debt and equity layers that each require independent validation. Most engagements land in the middle of their band. A short scoping conversation is usually enough to place a specific project within a few thousand dollars of its final fee.

Why This Matters More in 2026 Than It Did Last Year

USDA guaranteed lending is no longer a forgiving environment. The program is in the middle of the most aggressive portfolio cleanup in its history, and that has moved the bar for what counts as an acceptable feasibility study.

A few data points frame the shift. The B&I approval rate fell from roughly 89% in FY2021 to about 53% in FY2023, according to the federal banking regulator's mid-2025 review of the program. By early 2026, the active guaranteed balance had grown past $12 billion, with more than $1 billion delinquent and several hundred million dollars in repurchases and losses over a single twelve-month window.

The agency response has been blunt. In May 2026, USDA removed ten lenders from its guaranteed programs, citing portfolios that together held close to $620 million in delinquent loans, nearly half of all Rural Development delinquencies. Earlier in the year, the agency paused new anaerobic biodigester and controlled-environment-agriculture applications after delinquency rates in those categories climbed past 27% and 43% respectively. Wind projects became ineligible under B&I, and ground-mount solar above 50 kW now faces tighter screening.

There is a parallel tightening at the program design level. The October 2024 REAP funding notice, which had been expected to govern grant rounds through 2027, was rescinded in spring 2026 pending a rewrite of the underlying rule. Guaranteed REAP loans continue under 7 CFR Part 5001, but the grant pathway is in flux, and the agency has signaled a clear preference to steer renewable funding away from solar on productive farmland. For any energy project contemplating a combined grant-and-loan structure, the ground is shifting, and the feasibility analysis has to account for it.

The practical takeaway for a borrower or lender: agency review is stricter, slower to forgive a weak file, and far more attentive to the independent analysis behind a projection. A feasibility study that would have passed in 2021 can stall in 2026. The study is now doing more work than it ever has, and that is precisely why the cheapest version of it carries the most risk.

Complexity, Not Loan Size, Drives Cost

The single most common pricing misconception is that a larger loan means a larger study fee. It does not. A $25 million loan against a stabilized warehouse can cost less to evaluate than a $10 million loan for a first-of-its-kind processing plant. The workload follows the verification burden, not the dollar figure.

Two B&I scenarios illustrate the spread.

Scenario A: a $10 million hotel refinance. The borrower wants to retire high-cost debt, reflag to a stronger brand, and fund a furniture, fixtures, and equipment refresh. Complexity is low. The asset is a known quantity with years of operating history, a documented cash-flow record, and an abundance of comparable performance data, including franchise disclosure documents and revenue-per-available-room benchmarks. The analysis concentrates on the post-renovation revenue lift and confirming that the resulting debt service coverage satisfies the lender. This is the lower end of the fee range and the fastest turnaround.

Scenario B: a $100 million biotech facility. The capital stack combines a B&I loan, a REAP loan, C-PACE financing, New Markets Tax Credits, sponsor equity, and private capital. The work is extensive: independently confirming raw-material supply contracts, verifying that offtake buyers are creditworthy, assessing whether the core technology is commercially proven, mapping multi-entity ownership, and modeling several debt instruments across five to ten years. Every one of those steps consumes senior analyst time. This is the upper end, and the timeline reflects it.

The lesson is consistent across asset classes. Established, operating businesses with clean financial histories analyze quickly and price low. Novel concepts, ground-up developments, and layered capital structures require independent validation at every assumption, and that is where cost accrues. Two projects of identical loan size can sit at opposite ends of the fee table purely on the basis of how much of the underlying story has to be proven from scratch.

Why the Cheapest Study Is the Most Expensive

The market is full of template studies priced at $3,000 to $4,000, and a growing share are machine-generated with little independent analysis underneath. They are attractive until the application reaches the lender's credit committee or the USDA National Office and is returned for technical insufficiency, the single most cited reason for delay and rejection in the program.

When that happens, the initial saving evaporates. The borrower pays for a second study, absorbs three to six months of lost time, risks the loss of a rate lock or a construction window, and in the worst case watches the project fail to clear at all. In government-guaranteed lending, the feasibility study is the lens through which both the lender and the agency assess project risk. A weak lens does not save money. It defers and multiplies the cost.

The dynamic is worth spelling out because it is rarely priced into the borrower's first decision. A study returned for insufficiency does not simply cost the price of a replacement. It resets the clock on the entire financing. Interest rate environments move. Construction bids expire. Seller patience runs out on a purchase. Equity partners reassess. The second study is the smallest line item in that chain of consequences, which is why a study chosen on price alone so often turns out to be the single most expensive decision in the deal.

A credible study does the opposite. It functions as external validation that moves a file from a maybe to a yes, and it serves as an independent check on the sponsor's own assumptions, surfacing the questions a careful credit officer will ask before they ask them. The best studies are quietly persuasive: they anticipate the reviewer's objections and answer them inside the document, so the file moves rather than stalls.

What USDA Actually Requires

This is where most cost guides go quiet. Pricing is downstream of the regulation, so it helps to know what the regulation says.

Since October 2020, USDA's four guaranteed programs (Community Facilities, Water and Waste Disposal, Business and Industry, and REAP) have operated under a single rule, 7 CFR Part 5001, the OneRD Guarantee Loan Initiative. The feasibility requirements live in Subpart D, with the governing definition of a feasibility study set out at section 5001.3:

a report including an opinion or finding conducted by an independent qualified consultant evaluating the economic, market, technical, financial, and management feasibility of the proposed project in terms of its expectation for success.

Those five components are not optional. They are the spine of a compliant report, and a study that treats any one of them lightly is the kind of file that gets returned. It is worth understanding what each one is meant to establish.

Economic feasibility asks whether the project makes sense in its broader environment: the regional economy, the labor market, the demand fundamentals that sit underneath the specific business. Market feasibility examines the addressable demand for the project's product or service, the competitive set, pricing power, and the realism of the revenue assumptions. Technical feasibility evaluates whether the project can actually be built and operated as designed, covering construction approach, equipment, technology readiness, and operational scalability. Financial feasibility is the heart of the report, and it carries its own regulatory definition: the ability of the project to generate enough income, credit, and cash flow to sustain itself over the long term and meet every debt obligation. Management feasibility assesses whether the sponsor and operating team have the experience and capacity to execute the plan.

Appendix A to Subpart D specifies what each component must address in detail, and a study that maps cleanly to that appendix is one the reviewer can move through quickly. A study that buries or skips a component is one that invites a request for more information, and every such request adds weeks.

The independence requirement is equally firm. The consultant cannot hold an ownership, development, construction, brokerage, operating, or financing interest in the project. A study written by the borrower, or by a party with a stake in the outcome, is treated as biased and rarely survives review.

A useful way to read the framework is that the five feasibility components map directly onto the lender's Five Cs of credit (character, capacity, capital, collateral, and conditions) that the agency itself uses to evaluate a credit. Market feasibility, in particular, supports the conditions analysis. A study built to that structure speaks the reviewer's language. A generic study does not.

Program Mechanics That Shape the Engagement

The four programs differ in ways that directly affect the scope and cost of a study. A short orientation helps set expectations.

Business and Industry (B&I). The workhorse of rural lending. Loans run up to $25 million, with a higher ceiling for certain value-added agricultural cooperatives. Rural eligibility generally means a population of 50,000 or less. Eligible uses span acquisition, construction, modernization, equipment, debt refinance, and working capital. The guarantee reaches 85% on loans under $5 million and 80% on loans between $5 million and $25 million, a size-based tiering introduced for fiscal 2026. A debt service coverage ratio of 1.25 times is generally regarded as strong.

Rural Energy for America Program (REAP). Supports renewable energy systems and energy efficiency improvements through a combination of grants and guaranteed loans. Grants can reach 25% of eligible costs under the Farm Bill baseline and rose to 50% under recent funding that is now winding down. The feasibility analysis for a renewable energy system is required only when the lender or the agency calls for it, but a technical report is required for every project and scales with project cost. The fee on a REAP study is typically the lowest of the four programs, reflecting the narrower analytical scope.

Community Facilities (CF). Funds essential public infrastructure: hospitals and clinics, nursing homes, child care centers, town halls, courthouses, fire and police stations, and public-safety equipment. Guaranteed loans reach $100 million at an 80% guarantee. Borrowers are public bodies or non-profits serving a rural area. CF studies carry their own appendix and, in the heavier cases, an examination opinion standard that lifts both the rigor and the cost.

Section 9003 (Biorefinery Assistance). The most demanding program, guaranteeing loans up to $250 million for biorefineries, renewable chemicals, and biobased product manufacturing. Studies here move into technology readiness assessment, feedstock supply verification, offtake credit analysis, and multi-year sensitivity modeling. This is why Section 9003 sits at the top of the fee and timeline table and why it is the one program where a study should never be commissioned on price.

The fiscal 2026 fee schedule, published in the Federal Register, sets the upfront guarantee fee at 3.0% for B&I, 1.25% for Community Facilities, and 1.0% for REAP, with annual retention fees layered on top. Those fees are typically financed into the loan and passed through to the borrower, and they belong in any honest accounting of total project cost alongside the study fee itself.

When a Feasibility Study Is Mandatory

Not every USDA loan triggers a full independent study, and knowing the threshold avoids paying for analysis the file does not require.

B&I. An independent feasibility study is mandatory for guaranteed loans greater than $1 million made to a new entity or to an existing entity undertaking a new activity. For loans of $1 million or less, the agency may still require one at its discretion. A "new business," in the regulation's terms, is one operating less than a full year, or one operating longer without having reached stable, full operations. The agency also retains authority to require a study at any loan size when it cannot otherwise establish a clear basis for repayment.

Community Facilities. Every CF loan needs some form of financial feasibility report. A lighter analysis is permitted for loans of $25 million or less to existing facilities, for loans backed by a general-obligation bond or tax-supported revenue, or for borrowers with three years of audited statements demonstrating debt-service capacity. Outside those safe harbors, the heavier study with an examination opinion applies. Assisted-living and skilled-nursing projections are held to a ceiling of no more than 90% occupancy, a constraint that catches many sponsors by surprise and that a competent study builds in from the start.

REAP. A feasibility study is required for renewable-energy-system projects only when the lender or the agency deems it necessary, the most discretionary trigger in the framework. A technical report, by contrast, is required for every REAP project, scaled by total project cost.

Section 9003. These biorefinery and biobased-manufacturing loans, guaranteed up to $250 million, demand the most rigorous study in the program. That scope is why they sit at the top of the fee table.

The practical advice that follows from all of this: confirm the requirement before commissioning the work. A borrower who assumes a study is needed when a lighter analysis would satisfy the file can overpay, and a borrower who assumes none is needed can lose months when the agency requests one late. The threshold question is worth a conversation at the front of the process, not the back.

What Drives the Fee

Within any program, the engagement fee tracks the verification and modeling burden. The variables that move it most:

• Novelty and operating history. A proven, operating business with audited financials is faster and cheaper to evaluate than a startup or ground-up development that rests entirely on projections. Historical data is the cheapest input a study can have, because it replaces assumptions that would otherwise have to be researched and defended.

• Quality of comparable data. Asset classes with deep benchmarking, hospitality, RV and boat storage, self-storage, and branded franchise concepts among them, draw on extensive industry reporting and franchise disclosure documents. Emerging sectors with thin comparables require original research, and original research is what consumes senior time.

• Assumption testing. A serious study does not accept sponsor projections at face value. Pricing, utility loads, labor, byproduct revenue, and ramp-up timelines each get independently researched and stress-tested, and that work scales the fee.

• Modeling depth. A clean refinance may need only baseline projections. A phased development with multiple debt instruments needs multi-scenario modeling and long-horizon stress testing across several layers of the capital stack.

• Capital and ownership structure. Multi-entity ownership, holding-and-operating arrangements, and stacked combinations of loans, grants, and equity take substantially longer to model and document, because the cash flows between entities have to be traced and reconciled.

• Third-party verification. Independent confirmation of supply contracts, offtake agreements, leases, construction budgets, and counterparties expands the scope of diligence and, on larger projects, becomes the dominant cost.

• Lender-specific requirements. Different lenders apply different standards. Studies prepared for federal guarantee programs typically require more rigorous sensitivity analysis and more structured documentation than a conventional commercial loan.

• Regulatory alignment. Studies built to OneRD and program-specific standards require expertise that generic providers do not carry, and that expertise is part of what the fee reflects.

How We Deliver for Less, and Faster

Lower fees and shorter timelines invite a fair question: what is being skipped? Nothing that matters. The compression comes from method.

We run financial modeling on standardized, lender-calibrated frameworks rather than rebuilding each model from a blank page, which removes days of setup without touching the rigor of the output. We maintain proprietary datasets that mirror the screens federal reviewers apply, so verification that would otherwise require sequential outside requests happens in parallel and in-house. Engagements are scoped on a fixed fee at the outset, with senior analysts leading the work rather than handing it down, which keeps revision cycles short and avoids the back-and-forth that inflates both cost and calendar at less specialized firms.

There is also a quality dividend in this approach that pure speed obscures. Because the modeling framework is calibrated to the standard the agency applies, the study is built to pass on the first submission rather than retrofitted after a request for more information. The fastest path through agency review is a complete file, and a complete file is the product of method, not luck.

The result is a study that meets the same five-component standard the regulation demands, prepared in two to five weeks for most asset classes, at a fee positioned below the field. Speed and price are the visible outcome. Disciplined method is the cause.

Choosing a Provider

Price and turnaround are easy to compare on a quote. The harder and more important comparison is competence, and a few questions surface it quickly.

Ask whether the provider works to 7 CFR Part 5001 and Appendix A by name, and whether they can describe how the five components map to the file. Ask how many studies they have prepared in your specific asset class, because a hotel study and a biorefinery study are not interchangeable skills. Ask whether the model is built to the agency's coverage and occupancy constraints from the start, the 90% occupancy ceiling on senior care being the obvious test. Ask how they handle a request for more information from the agency, and whether revisions inside the original scope are included.

A provider who answers those questions crisply is one whose study is likely to clear review. A provider who deflects to price is selling a document, not a result. In a year when the approval rate has fallen to roughly half of applications, that distinction is the whole game.

Frequently Asked Questions

Can I write the feasibility study myself to save money? No. For most USDA and SBA loans above $1 million, the agency requires an independent third party. Even where it is not strictly required, a self-prepared study is treated as biased by lenders and sharply raises the odds of rejection.

Does a passing study guarantee a loan? No study can guarantee approval. What a strong study does is remove technical insufficiency, the most common cause of delay, as a reason for the file to stall.

Is the feasibility study cost tax-deductible? In most cases it is treated as a professional-service fee or a pre-development cost. Confirm the treatment for your entity with a CPA.

Can the cost be included in the loan? Often, yes. In many government-guaranteed financings the study fee is an eligible use of loan proceeds and is reimbursed at closing. One exception worth noting: for REAP grants, feasibility, audit, and engineering fees incurred before the complete-application date are not eligible project costs.

Does it matter whether the borrower or the lender orders the study? No. Either can commission it. Lenders frequently order the study, the appraisal, and other third-party reports directly and pass the cost through to the borrower without markup.

Does loan size determine the cost? Not on its own. A large loan against a simple, stabilized asset can cost less to study than a smaller loan for a complex processing facility. Complexity drives the workload.

How long does a study take? Across the market, four to seven weeks is typical. Our standard delivery runs two to five weeks depending on program and complexity, with faster turnaround available on simpler engagements.

Can one study serve both a USDA and an SBA loan? Often, yes. When a borrower is comparing programs, the study can be drafted to the higher common standard of both agencies, which avoids paying for two separate reports.

Will my lender accept a study from a consultant I chose? It depends on the lender. Some accept studies from a consultant the borrower engages directly; others prefer to select or approve the consultant themselves. Confirm the lender's preference at the front of the process, as the same question applies to appraisals and other third-party reports.

What is the most common reason a study fails? Technical insufficiency: a study that does not fully address one or more of the five required components, or that rests on assumptions it does not independently support. It is the leading cause of delay at the National Office and the failure a competent provider is built to avoid.

Request a Custom Quote

A weak document should never be the reason a sound project stalls. Our 2026 feasibility studies are built to the exact standards of USDA, SBA, and conventional lenders, priced transparently, and delivered on timelines that respect your closing window.

Tell us the program, the asset class, and the loan structure, and we will return a fixed-fee scope for your specific project.